- Investor Relations
- News Releases
- Management & Directors
- Corporate Governance
- Events & Presentations
- Financial Information
- Stock Information
- Investor FAQs
- Contact Us
STOCK INFORMATION
NASDAQ: ELGX
Price:
13.46
Change:
+ 0.16
Volume:
293,500
4:00 PM ET on Feb 3, 2012
Delayed at least 20min, by eSignal
Analyst Coverage
| Firm | Analyst |
|---|---|
| Capstone Investments | John Putnam |
| Oppenheimer | Steven Lichtman |
| Lazard Capital Markets | Sean Lavin |
| Piper Jaffray & Co. | Timothy J. Lee |
| Stephens Inc. | Chris Cooley |
| Wedbush Securities | Duane Nash |
Endologix is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Endologix's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Endologix or its management. Endologix does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.











